Status:
COMPLETED
Different Doses of Vitamin D and T Regulatory Cells in Preterm Infants
Lead Sponsor:
Cairo University
Conditions:
Prematurity
Immune Defect
Eligibility:
All Genders
Up to 28 years
Phase:
PHASE1
Brief Summary
This study evaluate the effect of two different doses of vitamin D on T-regulatory cells in preterm infants. Half of the subjects receives 400 IU vitamin D and the other half receives 800 IU vitamin D...
Detailed Description
Vitamin D, in addition to its bone mineralization effect, is an immune- modulatory agent. Fetal and premature cellular immunity are generally delayed. Whether vitamin D can enhance cellular immunity b...
Eligibility Criteria
Inclusion
- Preterm infants with gestational age 28-33 weeks
Exclusion
- Necrotizing enterocolitis
- Bowel perforation
- Chromosomal anomalies
- Inborn errors of metabolism
- Major congenital anomalies
Key Trial Info
Start Date :
January 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03793309
Start Date
January 9 2017
End Date
December 11 2017
Last Update
January 7 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.